TELA Bio, Inc. Announces 2024 Annual Meeting of Stockholders on June 4

TL;DR

<b>TELA Bio, Inc. is holding its 2024 Annual Meeting of Stockholders virtually on June 4, 2024.</b>

AI Summary

TELA Bio, Inc. (TELA) filed a Proxy Statement (DEF 14A) with the SEC on April 18, 2024. TELA Bio, Inc. will hold its 2024 Annual Meeting of Stockholders virtually on June 4, 2024, at 10:00 a.m. Eastern Time. The virtual format is chosen to enable global participation, reduce costs, and minimize environmental impact. Stockholders can access the meeting online at https://agm.issuerdirect.com/tela. The company is utilizing SEC rules to furnish proxy materials over the Internet. Taylor Ocasio, General Counsel & Corporate Secretary, can be contacted at 484-320-2930 for voting inquiries.

Why It Matters

For investors and stakeholders tracking TELA Bio, Inc., this filing contains several important signals. The virtual meeting format allows for broader stockholder participation from any location and is presented as a cost-saving and environmentally friendly alternative to a physical meeting. The company is leveraging SEC rules for internet-based delivery of proxy materials, indicating a move towards digital communication and potentially reduced printing and mailing costs.

Risk Assessment

Risk Level: low — TELA Bio, Inc. shows low risk based on this filing. The filing is a routine proxy statement for an annual meeting, with no significant new financial or operational information that would indicate high risk.

Analyst Insight

Stockholders should review the proxy statement for details on proposals and vote their shares prior to the June 4, 2024 meeting.

Key Numbers

• June 4, 2024 — Annual Meeting Date (Date of the 2024 Annual Meeting of Stockholders.)
• 10:00 a.m. Eastern Time — Annual Meeting Time (Time the 2024 Annual Meeting of Stockholders will commence.)
• 2024 — Annual Meeting Year (Year of the Annual Meeting of Stockholders.)

Key Players & Entities

• TELA Bio, Inc. (company) — Registrant and filer of the proxy statement.
• June 4, 2024 (date) — Date of the 2024 Annual Meeting of Stockholders.
• Taylor Ocasio (person) — General Counsel & Corporate Secretary for TELA Bio, Inc.
• 484-320-2930 (phone_number) — Contact number for voting inquiries.
• Doug Evans (person) — Chairman of the Board of Directors.

FAQ

Industry Context

TELA Bio, Inc. operates in the medical device industry, specifically focusing on surgical and medical instruments and apparatus.

Regulatory Implications

The filing is made under Section 14(a) of the Securities Exchange Act of 1934, which governs the solicitation of proxies.

What Investors Should Do

1. Review the full proxy statement for details on proposals to be voted on at the Annual Meeting.
2. Vote your shares prior to the June 4, 2024 meeting to ensure your voice is heard.
3. Contact Taylor Ocasio at 484-320-2930 with any questions regarding voting procedures.

Key Dates

• 2024-06-04: 2024 Annual Meeting of Stockholders — Key date for stockholders to vote and participate in company governance.
• 2024-04-18: Filing Date — Date the Definitive Proxy Statement was filed with the SEC.

Year-Over-Year Comparison

This filing is a Definitive Proxy Statement (DEF 14A) for the upcoming annual meeting, following the standard disclosure requirements for such filings.

Key Financial Figures

• $58.5 million — RATE HIGHLIGHTS Recognized revenue of $58.5 million for the full year 2023, representing an
• $8 million — en Pack to MiMedx Group in exchange for $8 million to $12 million in total consideration.
• $12 million — edx Group in exchange for $8 million to $12 million in total consideration. U.S. commerci
• $46.3 million — ulting in net proceeds of approximately $46.3 million after deducting underwriting discounts,

Filing Documents

• tm242754-1_def14a.htm (DEF 14A) — 841KB
• lg_telabior-4c.jpg (GRAPHIC) — 22KB
• ic_mail-bw.jpg (GRAPHIC) — 3KB
• ic_internet-bw.jpg (GRAPHIC) — 3KB
• ic_phone-bw.jpg (GRAPHIC) — 3KB
• ic_meeting-bw.jpg (GRAPHIC) — 3KB
• pc_breakdown-4c.jpg (GRAPHIC) — 13KB
• fc_effective-4c.jpg (GRAPHIC) — 98KB
• fc_stockholder-4c.jpg (GRAPHIC) — 72KB
• box_item1-4c.jpg (GRAPHIC) — 29KB
• box_item2-4c.jpg (GRAPHIC) — 40KB
• px_24telabioproxy1pg01-bw.jpg (GRAPHIC) — 212KB
• px_24telabioproxy1pg02-bw.jpg (GRAPHIC) — 222KB
• 0001104659-24-048835.txt (&nbsp;) — 1778KB

EXECUTIVE COMPENSATION

EXECUTIVE COMPENSATION 23 2023 SUMMARY COMPENSATION TABLE 23 PLEDGING AND HEDGING POLICIES 25 CLAWBACK POLICY 25 OUTSTANDING EQUITY AWARDS AT 2023 FISCAL YEAR-END 26 EMPLOYMENT AGREEMENTS 27 CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS 30 POLICIES AND PROCEDURES FOR RELATED PERSON TRANSACTIONS 30 EQUITY COMPENSATION PLAN INFORMATION 31

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT

SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT 32 ITEMS TO BE VOTED ON 34 PROPOSAL 1: ELECTION OF CLASS II DIRECTORS FOR A THREE-YEAR TERM EXPIRING IN 2027 34 PROPOSAL 2: RATIFICATION OF APPOINTMENT OF KPMG LLP AS OUR INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR 2024 35 Notice of Annual Meeting of Stockholders and2024 Proxy Statement |iii TABLE OF CONTENTS TABLE OF CONTENTS (continued) OTHER INFORMATION 36 OTHER MATTERS 36 REQUIREMENTS FOR SUBMISSION OF STOCKHOLDER PROPOSALS FOR NEXT YEAR'S ANNUAL MEETING 36 STOCKHOLDER COMMUNICATIONS TO THE BOARD 36 AVAILABILITY OF MATERIALS 37 PROXY STATEMENT This Proxy Statement is being furnished to stockholders of TELA in connection with the solicitation by our Board of proxies to be voted at our Annual Meeting and at any postponements or adjournments thereof. The Annual Meeting will be held on Tuesday, June 4, 2024, at 10:00 a.m., Eastern Time, via the Internet at https://agm.issuerdirect.com/tela . This Proxy Statement is first being furnished to our stockholders on or about April 18, 2024. The Notice of Internet Availability of Proxy Materials being mailed to the stockholders is not part of the Proxy Statement. iv| Notice of Annual Meeting of Stockholders and2024 Proxy Statement TABLE OF CONTENTS GENERAL INFORMATION ABOUT THE MEETING PROXY SOLICITATION Our Board is soliciting your vote on matters that will be presented at the Annual Meeting and at any adjournment or postponement thereof. This Proxy Statement contains information on these matters to assist you in voting your shares. This Proxy Statement and the proxy card are being furnished to our stockholders on or about April 18, 2024. This Proxy Statement and our 2023 Annual Report are available to holders of our common stock at www.edocumentview.com/TELA . If you would like to receive, without charge, a paper copy of our 2023 Annual Report, including the financial statements, please send

: Gender Identity

Part I: Gender Identity Directors 2 4 — —

: Demographic Background

Part II: Demographic Background African American or Black — — — — Alaskan Native or Native American — — — — Asian — — — — Hispanic or Latinx — — — — Native Hawaiian or Pacific Islander — — — — White 2 4 — — Two or More Races or Ethnicities — — — — LGBTQ+ — — — — Did Note Disclose Demographic Background — — — — Notice of Annual Meeting of Stockholders and2024 Proxy Statement |5 TABLE OF CONTENTS BOARD OF DIRECTORS (continued) BOARD OVERSIGHT OF COMPANY CULTURE AND ENVIRONMENTAL, SOCIAL AND GOVERNANCE HIGHLIGHTS Our Board is committed to fostering a strong culture of compliance and ethical conduct and has structured its committees and their activities to support its commitment. Our Board supports management's promotion of a corporate culture of integrity, ethical behavior and compliance with laws and regulations and for ensuring that the Company's culture and its strategy are aligned. Our Board expects all directors, as well as officers and employees, to conduct themselves in a manner consistent with our Code of Business Conduct and Ethics, or the Code of Conduct, and our values. Our Board believes that a strong culture of integrity, ethics and compliance is fundamental to the conduct of the Company's business, and is necessary for effective risk management, maintaining investor trust, and successful corporate governance. We understand corporate responsibility is essential for good governance because it strengthens the accountability of our Board and management team. We view ESG initiatives as long-term value drivers for the Company and our stockholders. Our focus on and commitment to ESG is tied to our belief that achieving and sustaining business excellence goes hand-in-hand with strong corporate leadership and stewardship. Our Board is primarily responsible for overseeing our corporate strategy, which

View Full Filing

View this DEF 14A filing on SEC EDGAR